Ilagan, Venjie A.

HRN: 27-77-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 750MG (VIAL)
09/09/2025
09/16/2025
IV
750mg
Q8
URTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines